Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Rose

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Physics in Medicine and Biology|September 16, 2020
IPEM Topical Report: An evidence and risk assessment based analysis of the efficacy of quality assurance tests on fluoroscopy units-part II; image qualityDan Shaw, Mark Worrall, Chris Baker, et al.
Melanoma Research|February 22, 2023
Screening costs associated with donor selection for fecal microbiota transplantation for treatment of PD-1 refractory melanoma patientsDylan Fortman, Maria G Pazan Avellan, Drew Hurd, et al.
Scientific Data|March 25, 2025
LandScan Global 30 Arcsecond Annual Global Gridded Population Datasets from 2000 to 2022Viswadeep Lebakula, Kelly Sims, Andrew Reith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 7, 2019
Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell TransplantationHaitham Abdelhakim, Leyla Shune, Sajjad Bhatti, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2009
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factorMiguel F Segura, Douglas Hanniford, Silvia Menendez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2018
Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced MelanomaDiwakar Davar, Hong Wang, Joe-Marc Chauvin, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanomaLilit Karapetyan, Anthony R Cillo, Shuaichao Wang, et al.
Journal for Immunotherapy of Cancer|November 16, 2021
Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanomaWalter J Storkus, Deena Maurer, Yan Lin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 26, 2018
Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical NeviShawn Tahata, Shivendra V Singh, Yan Lin, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Physics in Medicine and Biology|September 16, 2020
IPEM Topical Report: An evidence and risk assessment based analysis of the efficacy of quality assurance tests on fluoroscopy units-part II; image qualityDan Shaw, Mark Worrall, Chris Baker, et al.
Melanoma Research|February 22, 2023
Screening costs associated with donor selection for fecal microbiota transplantation for treatment of PD-1 refractory melanoma patientsDylan Fortman, Maria G Pazan Avellan, Drew Hurd, et al.
Scientific Data|March 25, 2025
LandScan Global 30 Arcsecond Annual Global Gridded Population Datasets from 2000 to 2022Viswadeep Lebakula, Kelly Sims, Andrew Reith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 7, 2019
Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell TransplantationHaitham Abdelhakim, Leyla Shune, Sajjad Bhatti, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2009
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factorMiguel F Segura, Douglas Hanniford, Silvia Menendez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2018
Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced MelanomaDiwakar Davar, Hong Wang, Joe-Marc Chauvin, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanomaLilit Karapetyan, Anthony R Cillo, Shuaichao Wang, et al.
Journal for Immunotherapy of Cancer|November 16, 2021
Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanomaWalter J Storkus, Deena Maurer, Yan Lin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 26, 2018
Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical NeviShawn Tahata, Shivendra V Singh, Yan Lin, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Pageof 5